1. Current Controversies and Challenges on BRAF V600K-Mutant Cutaneous Melanoma
   Alessandro Nepote et al, 2022, Journal of Clinical Medicine CrossRef
2. Effects of BRAF V600E and NRAS mutational status on the progression‑free survival and clinicopathological characteristics of patients with melanoma
   Tatjana Zablocka et al, 2022, Oncology Letters CrossRef
3. Assessment of RAS-RAF-MAPK Pathway Mutation Status in Healthy Skin, Benign Nevi, and Cutaneous Melanomas: Pilot Study Using Droplet Digital PCR
   Elena-Georgiana Dobre et al, 2024, International Journal of Molecular Sciences CrossRef
4. Cutaneous melanoma in older patients
   Alessandra Buja et al, 2024, BMC Geriatrics CrossRef
5. The Value of Histopathological Characteristics and BRAF and NRAS Mutations for the Diagnosis, Risk Stratification, and Prognosis of Malignant Invasive Melanoma
   Tatjana Zablocka et al, 2023, Melanoma - Standard of Care, Challenges, and Updates in Clinical Research CrossRef
6. Multimodal integration of image, epigenetic and clinical data to predict BRAF mutation status in melanoma
   Lucas Schneider et al, 2023, European Journal of Cancer CrossRef
7. Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies
   Valentina B. Stevenson et al, 2023, Frontiers in Veterinary Science CrossRef